Category: Latest News

Tempus AI (NASDAQ:TEM) surged 9% in premarket trading on Friday after the genetic testing company posted a smaller-than-expected loss per share for the second quarter and raised its revenue guidance. The firm reported a loss of $0.22 per share, beating analysts’ forecasted loss of $0.25. Revenue reached $314.6 million, surpassing the consensus estimate of $297.8…

Gray Media Inc. (NYSE:GTN) saw its shares rise 5.07% in after-hours trading on Friday following the release of its second-quarter financial results, which showed revenue above analyst forecasts despite a larger-than-expected loss. The multimedia broadcaster reported Q2 revenue of $772 million, beating the consensus estimate of $766.31 million, though this marked a 7% decline from…

Shares of Novo Nordisk (NYSE:NVO), traded in Copenhagen, rose over 5% on Friday, extending gains from the previous session. The boost came after rival Eli Lilly (NYSE:LLY) released trial results showing its weight-loss pill was less effective than Novo’s blockbuster drug, Wegovy. On Thursday, Lilly announced that its late-stage trial of the experimental GLP-1 pill,…

Shares of Block Inc (NYSE:XYZ) jumped 8% in premarket trading on Friday following the company’s second-quarter report that showcased impressive gross profit growth, even as adjusted earnings per share fell short of forecasts. Investor confidence was buoyed by solid performance in the Cash App and Square divisions, along with an upgraded full-year outlook. Block recorded…

VTEX (NYSE:VTEX) announced second-quarter results that fell short of subscription revenue expectations, leading the company to lower its growth projections for the rest of 2025 amid difficulties in Brazil and Argentina. The e-commerce platform provider’s subscription revenue increased 11.2% on a constant currency basis, missing the previously guided range of 12.5% to 15.5% and coming…

FibroGen Inc. (NASDAQ:FGEN) saw its stock jump nearly 10% after receiving encouraging feedback from the U.S. Food and Drug Administration (FDA) regarding the development of roxadustat for treating anemia in patients with low-risk myelodysplastic syndromes (LR-MDS) who rely heavily on red blood cell transfusions. The FDA’s positive response followed a Type C meeting where FibroGen…

Gilead Sciences (NASDAQ:GILD) saw its stock climb in after-hours trading on Friday, following an upbeat quarterly performance and a raised full-year outlook, driven by resilient demand for its HIV therapies. For the second quarter, the company reported adjusted earnings of $2.01 per share on revenue of $7.1 billion—both figures topping Wall Street expectations, which stood…

Taiwan Semiconductor Manufacturing Co. (NYSE:TSM) posted robust revenue growth in July, reflecting continued strength in artificial intelligence-driven chip demand. The company reported that its revenue for July climbed 25.8% year-over-year, reaching T$323.17 billion ($10.8 billion). Compared to June, sales rose 22.5%, signaling a strong mid-year performance. As a crucial supplier to major AI chipmakers like…

Twilio Inc. (NYSE:TWLO) shares plunged more than 12% in premarket trading on Friday after the company issued third-quarter earnings guidance that fell short of expectations, despite reporting better-than-expected results for the second quarter. For the quarter ending June 30, 2025, Twilio reported adjusted earnings of $1.19 per share on revenue of $1.23 billion, surpassing analyst…

Pinterest (NYSE:PINS) saw its shares drop more than 11% in U.S. premarket trading on Friday after the social media platform missed expectations for second-quarter revenue in its largest market, prompting concern among analysts. Analysts at Stifel highlighted that Pinterest’s sales performance in the U.S. and Canada lagged behind other digital advertising players. They pointed to…